A Clinical Study of Remimazolam Tosilate in Patients Undergoing Bronchoscopy

• Status: Recruiting
• Trial end date: 2020-12-30
• Target enrollment: 0
• Participant gender: All

Summary

A multicenter, randomized, single-blind, active controlled, parallel group study comparing remimazolam tosilate to propofol in patients undergoing bronchoscopy.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Jiangsu HengRui Medicine Co., Ltd.
• Treatments: Propofol

Criteria

Inclusion Criteria:

1. 18~80 years, female or male

2. Patients scheduled for an bronchoscopy procedure

3. 18 kg/m24. Patients understand clearly and participate in the study voluntarily, and sign the informed consent

Exclusion Criteria:

1. Patients scheduled for emergency surgery

2. Patients with a history of drug abuse and / or alcohol abuse 2 years prior to the screening period

3. One or more of the laboratory findings fall out of the limitations for this study(platelet,hemoglobin,aspartate aminotransferase,etc.);

4. Pregnant women or those in lactation period

5. Allergic to drugs used in the study

6. Patients have participated in other clinical trial within the 3 months prior to randomization

7. Any patient judged by the Principal Investigator (PI) or Sub-Investigator to be inappropriate for the subject for any other reason